Jumping into the vaccine gold mine... or landmine?


In July, the government had agreed for the facilities owned by Pharmaniaga Bhd and Duopharma Biotech Bhd to be used for the fill and finish process of the Covid-19 vaccine.

THE latest buzzword in the market now is vaccine, amid all the fanfare surrounding rubber glove makers who have been enjoying a spectacular run in the coronavirus disease (Covid-19) race.

If there is something that will stop the dominance of rubber gloves in their tracks it will have to be the development of a vaccine.

Get 20% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 11.12/month

Billed as RM 11.12 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 9.87/month

Billed as RM 118.40 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
vaccine , distribution , Duopharma , NRPA , Pharmaniaga , Covid-19 ,

Next In Business News

Trading ideas: AEON Credit, Mi Tech, Keyfield, Kee Ming, XL, Ann Joo, Sealink, TFP, Ecobuilt, Eckem, SSF
FORGING BUMIPUTERA CHAMPIONS
Reset expected for lenders in 2H26
Sealink seeks higher offer for Carimin deal
LB Aluminium cautiously optimistic on profitability
Private sector investments to buoy building sector in 2H26
Ringgit to continue being driven by external factors
Keyfield wins jobs worth RM229mil
OCBC leads the way in�sustainable finance�
Eckem IPO oversubscribed by 8.09 times

Others Also Read